SGS Quay Pharmaceuticals

CDMO - Our Global Center of Excellence for Formulation and Clinical Manufacturing in the UK provides enhanced formulation research and development services for phase I, phase II, and phase III trials.

Preclinical Formulation Screening - We provide a structured pre-formulation pathway to ensure the efficient screening of lead candidates, maximizing the dose that can be administered and is available for absorption.

Formulation Development - Pharmaceutical development and dosage form optimization for a wide range of product types, including those that have poor solubility or bioavailability.

Clinical Manufacturing - We offer a comprehensive range of clinical manufacturing services to help ensure your drug product uses the right delivery approach. With MHRA and FDA inspected facilities, we are licensed to manufacture non-sterile Phase I to III medicines.

SGS Pace – accelerated drug development pathway - SGS PACE brings together all the phases of drug development that would traditionally be handled by separate organizations and vendors – greatly improving efficiency.

Your bespoke SGS PACE solution provides an exclusive tailor-made program, designed with your objectives and goals in mind for your pace and budget. The customized program will deliver your clinical results effectively and efficiently.